Moberg Pharma's Fungal Nail Product Approved in China

Moberg Pharma AB of Sweden said its partner, Menarini Asia-Pacific, received China approval to market Kerasal Nail™, an OTC fungal nail product. Kerasal Nail treats nails that are discolored/deformed from fungal infection or psoriasis. First approved in Sweden in 2011, Kerasal is now available in more than 25 countries. Menarini distributes the product in Italy, and in 2013, its Menarini Asia-Pacific division became Kerasal Nail's distributor for China and eight APAC countries. More details.... Stock Symbol: (OMX: MOB) Share this with colleagues: // //